📣 The #EULAR Task Force on #COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021)!
Read about vaccination effectiveness and safety, as well as other frequently asked questions by people with RMDs.
👉 https://t.co/medFU72aM9
🙋♂️ Patients, join the movement #EULAR2021!
🌍 Register to develop your understanding of cutting-edge knowledge on treatments, best practices, and more!
👉 https://t.co/ISveSzffEr
💻 Join us to learn, engage, network and play & win!
📅 2-5 June, and on-demand until 5 July
💼 The #EULAR2020Forum event will explore the challenges faced by people living with #RMDs, and the practical and policy measures that can meet their #employment needs.
📣 Join the conversation 📅 12 October, 14:00-15:30 CET
📺 https://t.co/7PyQRh1Ka1
🌐 https://t.co/ZOuic4r8yH
“#Hydroxychloroquine is a tried and tested drug for #rheumatoidarthritis and particularly #lupus... patients who are already immunosuppressed, so they are part of a vulnerable group"
Excerpt from the interview to EULAR President for the Financial Times by @Mikepeeljourno#COVID19
EULAR Guidance for patients with rheumatic musculoskeletal diseases (RMDs) about COVID-19 outbreak. Protect yourself & others.
Read the full guidance:
https://t.co/nFp9Brmv3T
#EULAR#FightingRMDsTogether#eularPARE
8 days left to #EULAR2019 congress sharing the latest scientific and clinical instalments!
We are streaming for the first time! Subscribe to EULAR’s YouTube channel to watch congress news, the #livestream of selected sessions, and more!
https://t.co/bDfI75pE6y